Privatize the Gains, Socialize the Costs: A Framework for Understanding How American Markets Actually Work

The Pattern Has a Name

Call it what it is: the gains go private, the costs go public.

Charles Hugh Smith, writing via his OfTwoMinds blog and republished at ZeroHedge, lays out the mechanic plainly. Entities that control markets—whether through corporate monopoly, regulatory capture, or public-private hybrids—have a structural incentive to concentrate profit for insiders while distributing risk and long-term damage across a population large enough that no individual hurt feels decisive enough to fight back.

Smith's correspondent Simons Chase phrases it cleanly: "Privatize the Gains, Socialize the Costs."

This is not a partisan claim. It describes a system design, not a party platform. Republicans have built it. Democrats have built it. Lobbyists from every industry have paid to keep it running.

The Junk Food Case Study

Chase uses the food industry as an illustration, and the numbers are hard to dismiss.

A 2013 Forbes piece by Dan Munro tied roughly $1 trillion per year in U.S. healthcare spending to sugar consumption. Credit Suisse, in a separate analysis, placed 30% to 40% of total U.S. healthcare spending at the feet of diet-related illness. The 2012 Global Burden of Disease report found obesity a bigger global threat than hunger.

The food company books the revenue. The consumer gets the Type 2 diabetes. Medicaid, Medicare, employer-sponsored insurance, and personal bankruptcy absorb the long-term tab.

Chase frames this as "a leveraged recapitalization." The corporation pays a little now (ingredient costs, marketing) and collects the short-term gain, while the long-term cost lands on the public healthcare system years or decades later, diffused across millions of individual tragedies.

That is the mechanism. The product is profitable. The externality is someone else's problem.

As Chase puts it: the top employer in most states flipped from manufacturing to healthcare in a single generation. "We stopped making things and started billing the disease. The damage became the GDP."

Why the System Perpetuates Itself

Smith's structural argument is worth taking seriously regardless of your politics.

When costs are diffused across a huge population in small increments, no single voter or consumer experiences enough concentrated pain to organize a response. The person paying more per month in health premiums because diet-related illness is driving up the insurance pool does not connect that cost to a specific company's product strategy. The causal chain is too long and too blurry.

Meanwhile, the concentrated beneficiary—the food conglomerate, the pharmaceutical company, the financial firm—has every incentive to spend heavily on lobbying to keep the arrangement intact. The system rewards extraction and punishes transparency.

The Strongest Counterargument

Skeptics of this framing make a fair point: markets also deliver enormous benefits that are NOT socialized. Cheap calories, whatever their long-term cost, did reduce acute hunger. The same food system that produces junk food also produces affordable protein at a scale that would have been unimaginable to prior generations. Innovation in pharmaceuticals, even when priced badly, has extended lifespans. The framework of "privatize gains, socialize costs" can become a rhetorical sledgehammer that makes every profitable business look like a racket.

The question is not whether private enterprise creates value—it does—but whether specific structural arrangements are designed to exfiltrate that value while offloading liabilities onto taxpayers and consumers who have no say in the arrangement.

Both things can be true: markets are genuinely productive AND specific industries have been deliberately architected to collect profit while government absorbs the cleanup.

Who Actually Owns This Problem

No party gets to claim clean hands here.

Republican-aligned policymakers have routinely blocked food labeling reforms, protected agricultural subsidies for corn syrup production, and opposed regulatory action on processed food marketing to children. The argument is usually "government overreach" and "market freedom." But the market being protected is one that depends on public insurance to absorb its health costs.

Democrat-aligned policymakers have expanded Medicaid and the ACA in ways that, whatever their humanitarian intent, also function as a subsidy to industries producing diet-related illness. Every dollar of public coverage for a preventable diabetes complication is a dollar that insulates a food company from the downstream consequences of its product.

Both sides have constituencies that benefit from the status quo. Neither has produced a durable policy that changes the underlying incentive.

The Unresolved Question

The trillion-dollar number Munro cited in 2013 is now more than a decade old. U.S. healthcare spending has grown substantially since then. If the diet-related share has held anywhere near the Credit Suisse estimate of 30% to 40%, the socialized cost of privatized food profits has grown proportionally.

What no source in this story answers is whether any current legislative proposal would actually restructure these incentives, or whether such proposals would simply shift which taxpayers absorb the cost.